- Home
- XNCR vs UTL Comparison
XNCR vs UTL Comparison
Compare XNCR & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | UTL |
|---|---|---|
| Founded | 1997 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 937.1M | 906.9M |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | XNCR | UTL |
|---|---|---|
| Price | $14.36 | $52.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $22.33 | ★ $56.50 |
| AVG Volume (30 Days) | ★ 715.1K | 113.5K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | ★ 65.36 | 1.37 |
| EPS | N/A | ★ 1.85 |
| Revenue | $125,576,000.00 | ★ $536,000,000.00 |
| Revenue This Year | N/A | $5.43 |
| Revenue Next Year | $4.80 | $4.22 |
| P/E Ratio | ★ N/A | $27.58 |
| Revenue Growth | ★ 13.65 | 8.33 |
| 52 Week Low | $6.92 | $45.11 |
| 52 Week High | $18.69 | $55.08 |
Technical Indicators
Market Signals| Indicator | XNCR | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 71.07 | 56.51 |
| Support Level | $10.94 | $49.18 |
| Resistance Level | $14.54 | $53.32 |
| Average True Range (ATR) | 0.67 | 1.36 |
| MACD | 0.28 | 0.13 |
| Stochastic Oscillator | 95.45 | 71.51 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About UTL UNITIL Corporation
Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.